Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience

INTRODUCTION: Immune checkpoint inhibitor (ICI) pneumonitis causes substantial morbidity and mortality. Estimates of real-world incidence and reported risk factors vary substantially. METHODS: We conducted a retrospective review of 419 patients with advanced non-small cell lung cancer (NSCLC) who we...

Descripción completa

Detalles Bibliográficos
Autores principales: Altan, Mehmet, Soto, Felipe, Zhong, Linda L, Akhmedzhanov, Fechukwu O, Wilson, Nathaniel R, Zarifa, Abdulrazzak, Albittar, Aya A, Yang, Vincent, Lewis, Jeff, Rinsurongkawong, Waree, Jack Lee, J, Rinsurongkawong, Vadeerat, Zhang, Jianjun, Gibbons, Don L, Vaporciyan, Ara A, Jennings, Kristofer, Khawaja, Fareed, Faiz, Saadia A, Shannon, Vickie R, Shroff, Girish, Godoy, Myrna C B, Daver, Naval G, Gandhi, Saumil, Mendoza, Tito R, Naing, Aung, Daniel-MacDougall, Carrie, Heymach, John V, Sheshadri, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628566/
https://www.ncbi.nlm.nih.gov/pubmed/37156009
http://dx.doi.org/10.1093/oncolo/oyad118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628566/
https://www.ncbi.nlm.nih.gov/pubmed/37156009
http://dx.doi.org/10.1093/oncolo/oyad118

Ejemplares similares